Etuvetidigene Autotemcel: First Approval

Molecular Diagnosis and Therapy · Published 2026-03-25 · DOI 10.1007/s40291-026-00843-8

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40291-026-00843-8

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Gene therapy approaches for inborn errors of immunity: from bench to bedside · EXPERT OPINION ON BIOLOGICAL THERAPY · 2026 · Cites or is cited by this article
• Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis · Molecular Diagnosis and Therapy · 2025 · Same journal
• Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine · Molecular Diagnosis and Therapy · 2025 · Same journal
• Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies · Molecular Diagnosis and Therapy · 2025 · Same journal
• Tividenofusp Alfa: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal
• Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics · Molecular Diagnosis and Therapy · 2026 · Same journal
• The Future of Chemogenetics for the Treatment of Spasticity · Molecular Diagnosis and Therapy · 2025 · Same journal
• TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors · Molecular Diagnosis and Therapy · 2026 · Same journal
• Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy · Molecular Diagnosis and Therapy · 2026 · Same journal
• Marnetegragene Autotemcel: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal